Background: The Five Welfare Needs in UK animal welfare legislation underpin a legal duty of care and are an animal welfare assessment framework. Health and welfare problems arise when these needs are unmet. The veterinary professions work with others to address these problems, but there is no publicly funded U.K. companion animal welfare surveillance to identify priorities, or promote and monitor change. Methods: The veterinary charity, the People's Dispensary for Sick Animals (PDSA), together with the market research organisation, YouGov, has undertaken a longitudinal nationwide survey, assessing whether the U.K.'s pet dogs, cats and rabbits are having their Five Welfare Needs met. Data from nationally representative samples of pet-owning adults, drawn from YouGov's online survey panel, have been used to produce the PDSA Animal Wellbeing (PAW) Report annually since 2011. Results: Examples are given of how the PAW Report has been used to monitor trends in animal welfare problems, drive collaborative behaviour change campaigns, create evidence-based funding applications and inspire innovation in veterinary practice. Conclusion:The PAW Report has contributed to closing a gap in national companion animal welfare surveillance. When governments rely on nongovernmental organisations to assist with animal welfare surveillance, reliable sources such as the PAW Report can inform research, policy and legislation.This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
BackgroundVeterinary animal welfare advocacy can be undertaken at individual, community, national and international levels. The People’s Dispensary for Sick Animals (PDSA), a veterinary charity with 48 Pet Hospitals UK-wide, created a consultative staff network to put an explicit organisational focus on animal welfare–focused veterinary practice.MethodsPDSA created a national internal committee—a Pet Wellbeing Task Force—composed of veterinary staff representatives. Together with recruited hospital-based Champions who serve as a focus for animal welfare and ethics within their clinical teams, the resulting staff network has described a vision of animal welfare and ethics within companion animal veterinary practice, with accompanying practice-level actions. These actions have formed the basis for national clinical audit, repeated three times since 2013.ResultsThe audit, alongside targeted interventions, has driven organisational change (eg, new policies), led to measurable improvements in pet wellbeing (eg, improved pain assessment and management) and stimulated collaborative practice-based research with universities.ConclusionA dedicated staff network has facilitated organisation-wide communication on animal welfare and ethics; offered a safe space to raise and discuss animal welfare and ethical issues; and fostered leadership, by working towards model veterinary practice with respect to animal welfare and ethics, with benefits for pet patients, staff and the wider veterinary and veterinary nursing professions.
No abstract
To identify serum biomarkers differentiating dogs with and without osteoarthritis (OA). MethodsFollowing institutional ethical approval, 24 dogs (27.2-48.5 kg, 3.6-13.6 years) previously diagnosed with OA affecting different joints with varying severity were included in the study. Sixteen dogs (16.2-36 kg, 2.0-6.7 years) without detectable orthopaedic pathology were included as clinically healthy controls. Other disorders were ruled out by thorough clinical examinations and standard hematological and biochemical analyses. Serum was stored at -80 o C until analysis of five biomarkers using commercially available enzyme-linked immunosorbent assays: hyaloronic acid (HA), matrix metalloproteinase 13 (MMP-13), procollagen type IIA (PIIANP), cartilage oligomeric matrix protein (COMP), and collagen type-2 cleavage (C2C). Medians and confidence intervals were calculated and differences between groups were tested for significance using Mann Whitney tests (p<0.05). ResultsHigher concentrations of C2C and MMP-13 were observed in dogs with OA (median, [95% CIs] C2C: 23.7 ng/ml [18.2; 45.2 ng/ml], MMP-13: 0.70 ng/ml [0.51;1.09 ng/ml]) compared to clinically healthy dogs (C2C: 12.3 ng/ml [10.1; 35.3 ng/ml], MMP 13: 0.34 ng/ml [0.27; 0.88 ng/ml]), whereas lower concentrations of PIIANP were observed in dogs with OA (11.6 ng/ml [10.7; 18.02 ng/ml] compared to clinically healthy dogs (15.8 ng/ml [11.7; 31.7 ng/ml]). Observed differences were not significant. Statement (conclusions)None of the 5 biomarkers measured in the present study could differentiate heterogeneous groups of dogs with and without OA. Further studies are recommended to investigate possible diagnostic potentials of C2C, MMP-13 or PIIANP in subgroups of dogs with OA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.